StartsideBBN • SWX
add
Bellevue Group AG
Forrige sluttkurs
14,75 CHF
Dagsintervall
14,50 CHF - 14,80 CHF
Årsintervall
11,05 CHF - 24,30 CHF
Markedsverdi
195,19 mill. CHF
Gjennomsnittlig volum
9,95k
P/E-tall
13,08
Utbytte
7,93 %
Hovedbørs
SWX
Markedsnyheter
IVZ
0,97 %
0,78 %
0,11 %
Økonomi
Resultatregnskap
Omsetning
Nettoomsetning
(CHF) | juni 2024info | Endring år til år |
---|---|---|
Omsetning | 18,41 mill. | −11,31 % |
Driftskostnader | 13,73 mill. | −10,56 % |
Nettoomsetning | 3,72 mill. | −7,22 % |
Netto resultatmargin | 20,18 | 4,61 % |
Fortjeneste per aksje | — | — |
EBITDA | — | — |
Faktisk avgiftssats | 17,26 % | — |
Balanseregnskap
Totale aktiva
Totale passiva
(CHF) | juni 2024info | Endring år til år |
---|---|---|
Kontant / kortsiktige inv. | 30,49 mill. | 100,63 % |
Totale aktiva | 138,75 mill. | −4,69 % |
Totale passiva | 22,05 mill. | −24,81 % |
Total egenkapital | 116,70 mill. | — |
Utestående aksjer | 13,20 mill. | — |
P/B-forhold | 1,67 | — |
Avkastning på aktiva | 10,71 % | — |
Avkastning på kapital | — | — |
Kontantstrøm
Netto kontantstrøm
(CHF) | juni 2024info | Endring år til år |
---|---|---|
Nettoomsetning | 3,72 mill. | −7,22 % |
Kontantstrøm fra drift | 3,65 mill. | 137,31 % |
Kontanter fra investering | — | — |
Kontanter fra finansiering | −8,10 mill. | 45,85 % |
Netto kontantstrøm | −4,17 mill. | 83,13 % |
Fri kontantstrøm | — | — |
Om
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
Administrerende direktør
Grunnlagt
1993
Nettsted
Ansatte
88